Effect of Local Anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) Cream and Reduction in Dose, Pain and Intravenous Analgesic During Permanent Pacemaker Implantation

• Status: Unknown status
• Trial end date: 2014-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators believe that the local anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) cream will lessen pain and reduce the need for anesthesia and analgesia, when implanting a permanent pacemaker.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hillel Yaffe Medical Center
• Treatments: Analgesics; EMLA; Meperidine; Midazolam

Criteria

Inclusion Criteria:

• All patients undergoing pacemaker implantation

Exclusion Criteria:

• Dementia Patients

• Psychiatric Patients

• Unconscious Patients

• Patients with sensitivity to EMLA